Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT) — Stella

Home/Clostridioides Difficile Infection/

View on ClinicalTrials.gov

Recruiting

Back to Clostridioides Difficile Infection trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

UVA Health Systems, Charlottesville, Virginia

Carilion Clinic, Roanoke, Virginia

Key details

Phase

Safety & dosing

Sponsor

University of Virginia

Collaborators

Carilion Clinic, University of Southampton

Enrollment target

~260 participants

Started

June 2021

Primary completion

December 2026

Age range

18 Years – 105 Years

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.